R&D Systems™ Recombinant Human VSIG10L Fc Chimera Protein

Catalog No.	Quantity
96-00V-S050	50 μg

Catalog No. 96-00V-S050 Supplier R&D Systems™ Supplier No. 9600VS050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 1-6 μg/mL.

Specifications

• Accession Number: Q86VR7-1
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 147645
• Molecular Weight (g/mol): M.W. (Observed): 120-140 kDa, reducing conditions; M.W. (theoretical): 106 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human VSIG10L protein Human VSIG10L (Leu28-Ala776) (N-terminus) Accession # Q86VR7-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: V-Set And Immunoglobulin Domain Containing 10 Like, V-Set And Immunoglobulin Domain-Containing Protein 10-Like
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 200 μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: VSIG10L